LINX_SPHJU
ID LINX_SPHJU Reviewed; 250 AA.
AC D4Z260; P50198;
DT 18-JUL-2018, integrated into UniProtKB/Swiss-Prot.
DT 15-JUN-2010, sequence version 1.
DT 03-AUG-2022, entry version 60.
DE RecName: Full=2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase LinX {ECO:0000303|PubMed:7515041};
DE Short=2,5-DDOL dehydrogenase {ECO:0000303|PubMed:7515041};
DE EC=1.1.1.- {ECO:0000269|PubMed:7515041};
GN Name=linX {ECO:0000303|PubMed:7515041};
GN OrderedLocusNames=SJA_C1-18580 {ECO:0000312|EMBL:BAI96692.1};
OS Sphingobium japonicum (strain DSM 16413 / CCM 7287 / MTCC 6362 / UT26 /
OS NBRC 101211 / UT26S).
OC Bacteria; Proteobacteria; Alphaproteobacteria; Sphingomonadales;
OC Sphingomonadaceae; Sphingobium.
OX NCBI_TaxID=452662;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX PubMed=7515041; DOI=10.1128/jb.176.11.3117-3125.1994;
RA Nagata Y., Ohtomo R., Miyauchi K., Fukuda M., Yano K., Takagi M.;
RT "Cloning and sequencing of a 2,5-dichloro-2,5-cyclohexadiene-1,4-diol
RT dehydrogenase gene involved in the degradation of gamma-
RT hexachlorocyclohexane in Pseudomonas paucimobilis.";
RL J. Bacteriol. 176:3117-3125(1994).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=DSM 16413 / CCM 7287 / MTCC 6362 / UT26 / NBRC 101211 / UT26S;
RX PubMed=20817768; DOI=10.1128/jb.00961-10;
RA Nagata Y., Ohtsubo Y., Endo R., Ichikawa N., Ankai A., Oguchi A., Fukui S.,
RA Fujita N., Tsuda M.;
RT "Complete genome sequence of the representative gamma-
RT hexachlorocyclohexane-degrading bacterium Sphingobium japonicum UT26.";
RL J. Bacteriol. 192:5852-5853(2010).
CC -!- FUNCTION: Catalyzes the degradation of 2,5-dichloro-2,5-cyclohexadiene-
CC 1,4-diol (2,5-DDOL) into 2,5-dichlorohydroquinone (2,5-DCHQ) in vitro.
CC LinX appears not to be involved in gamma-hexachlorocyclohexane (gamma-
CC HCH) degradation pathway, in contrast to LinC which has the same
CC enzymatic activity. {ECO:0000269|PubMed:7515041}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2,5-dichlorocyclohexa-2,5-dien-1,4-diol + NAD(+) = 2,5-
CC dichlorohydroquinone + H(+) + NADH; Xref=Rhea:RHEA:15741,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:27545, ChEBI:CHEBI:28975,
CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC Evidence={ECO:0000269|PubMed:7515041};
CC -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D23722; BAA04939.1; -; Genomic_DNA.
DR EMBL; AP010803; BAI96692.1; -; Genomic_DNA.
DR RefSeq; WP_007682029.1; NC_014006.1.
DR AlphaFoldDB; D4Z260; -.
DR SMR; D4Z260; -.
DR STRING; 452662.SJA_C1-18580; -.
DR EnsemblBacteria; BAI96692; BAI96692; SJA_C1-18580.
DR KEGG; sjp:SJA_C1-18580; -.
DR eggNOG; COG1028; Bacteria.
DR HOGENOM; CLU_010194_1_0_5; -.
DR OMA; AKDANTM; -.
DR Proteomes; UP000007753; Chromosome 1.
DR GO; GO:0018502; F:2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity; IEA:RHEA.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR InterPro; IPR002347; SDR_fam.
DR PRINTS; PR00081; GDHRDH.
DR PRINTS; PR00080; SDRFAMILY.
DR SUPFAM; SSF51735; SSF51735; 1.
DR PROSITE; PS00061; ADH_SHORT; 1.
PE 1: Evidence at protein level;
KW NAD; Oxidoreductase; Reference proteome.
FT CHAIN 1..250
FT /note="2,5-dichloro-2,5-cyclohexadiene-1,4-diol
FT dehydrogenase LinX"
FT /id="PRO_0000054720"
FT ACT_SITE 156
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT BINDING 9..34
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 143
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT CONFLICT 80..81
FT /note="EA -> DG (in Ref. 1; BAA04939)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 250 AA; 25520 MW; 0B4CB3A6E8F5C9DD CRC64;
MANRLAGKVA LITGGASGLG AAQAKRFAEE GAKVVIGDLN EEMAKGVVAE IRAAGGDALF
IRLDVTDAAS WNNAIAAAVE AFGGLTTLSN TAGIIHPGGF EEESIEGWNK MVAVNQTAIF
LGIKAAIPEL VKSGNGSIIN ISSLIGMFPT AGNASYCATK AAVRIMSKAA ALEFVDRGVR
VNTIVPGGMN TPITANVPPD VLKQQTSQIP MGKLGDPIDI ANGALFLASD EAKYITGVDL
PIDGGWSVGV